CTOs on the Move

NextGate

www.nextgate.com

 
NextGate`s mission is to address the fundamental challenge of data management in the healthcare industry: the uncertainties and missed opportunities caused by duplicate and disconnected records in a data population. While implementing interface engine technology for hospitals in the early 1990s, we noticed a troubling trend – as application systems became integrated and exchanged data with each other, problems caused by duplicate and incomplete patient records (previously confined to one system and its MPI) multiplied and contaminated the data quality of other systems. Because this technical issue could impact a patient`s health, we made it our goal to find a solution. The ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nextgate.com
  • 3579 E. Foothill Blvd. Suite #587
    Pasadena, CA USA 91107
  • Phone: 626.376.4100

Executives

Name Title Contact Details
Greg Rumple
Chief Information Security Officer Profile

Similar Companies

MDoffice

MDoffice is a Edison, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cornerstone Specialty Network

Cornerstone Specialty Network is a company that provides value to community-based oncology practices through network aggregation, delivering value-added opportunities that support independence and long-term sustainability for community oncology practices.

Knight Therapeutics Inc

Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.

Windy City Cannabis

Windy City Cannabis is your Chicagoland dispensary. Visit our medical and recreational dispensary locations near you in Homewood, Justice, Posen and Worth.

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.